CompletedPhase 2

Safety and Efficacy of Bepotastine Besilate Ophthalmic Solution in Seasonal Allergic Conjunctivitis Patients

United States245 participantsStarted 2010-06

Plain-language summary

The purpose of this study is to study the safety and efficacy of bepotastine besilate ophthalmic solution in allergic conjunctivitis patients.

Who can participate

Age range12 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Subjects 12 years of age and older with 2-year history of allergic conjunctivitis Exclusion Criteria: * No active ocular or nasal infection

What they're measuring

Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) - Mean Change in Total Score

Timeframe: Baseline, 14 days

Trial details

NCT IDNCT01174823

SponsorBausch & Lomb Incorporated

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2010-10

Results submitted2020-08-24

View on ClinicalTrials.gov More Allergic Conjunctivitis trials